Clinical Study
Immunological Aspects in Late Phase of Living Donor Liver Transplant Patients: Usefulness of Monitoring Peripheral Blood CD4+ Adenosine Triphosphate Activity
Table 1
Characteristics of the 49 patients.
| ||||||||||||||||||||||||||||||||||||||||||
LDLT: living donor liver transplantation, HCV: hepatitis C virus, HCC: hepatocellular carcinoma, HBV: hepatitis B virus, PBC: primary biliary cirrhosis, LC: liver cirrhosis, FH: fulminant hepatitis, ALT: alanine aminotransferase, TB: total bilirubin, WBC: white blood cell count, C/D ratio: tacrolimus concentration/dose ratio. |